The chronicles of hepatocellular carcinoma classification: Subtyping, modeling, and treatment.
作者信息
Shimada Shu, Tanaka Shinji
机构信息
Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
出版信息
Hepatology. 2024 Feb 1;79(2):261-263. doi: 10.1097/HEP.0000000000000588. Epub 2023 Aug 30.
PMID:37651225
Abstract
摘要
相似文献
1
The chronicles of hepatocellular carcinoma classification: Subtyping, modeling, and treatment.肝细胞癌分类编年史：亚型、建模与治疗
Hepatology. 2024 Feb 1;79(2):261-263. doi: 10.1097/HEP.0000000000000588. Epub 2023 Aug 30.
2
Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.肿瘤大小仍是预测肝移植后肝细胞癌复发的关键因素。
Ann Surg Oncol. 2011 May;18(5):1217-8. doi: 10.1245/s10434-011-1589-3.
3
Treatment of hepatocellular carcinoma.肝细胞癌的治疗
Hepatology. 1997 Feb;25(2):259-62. doi: 10.1053/jhep.1997.v25.ajhep0250259.
4
Current status of treatment of hepatocellular carcinoma.肝细胞癌的治疗现状
Chin Med J (Engl). 1985 Apr;98(4):257-64.
5
Hepatocellular carcinoma in the era of immunotherapy.免疫治疗时代的肝细胞癌
Curr Probl Cancer. 2018 Jan-Feb;42(1):40-48. doi: 10.1016/j.currproblcancer.2017.10.007. Epub 2017 Nov 15.
6
Therapy Options for Patients With Hepatocellular Carcinoma.肝细胞癌患者的治疗选择
Oncology (Williston Park). 2019 Sep 20;33(9):685018.
7
Treatment of hepatocellular carcinoma.
Clin Gastroenterol Hepatol. 2003 Jan;1(1):10-8. doi: 10.1053/jcgh.2003.50003.
8
Focus on treatment of large hepatocellular carcinoma.专注于大肝细胞癌的治疗。
Ann Surg Oncol. 2004 Dec;11(12):1035-6. doi: 10.1245/ASO.2004.10.906.
9
Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis.肝细胞癌合并 Child-Pugh-Turcotte 级肝硬化患者的非移植治疗方法。
Lancet Oncol. 2017 Feb;18(2):e101-e112. doi: 10.1016/S1470-2045(16)30569-1.
10
Predicting survival in early hepatocellular carcinoma.预测早期肝细胞癌的生存率。
Gut. 2005 Mar;54(3):328-9. doi: 10.1136/gut.2004.052092.
引用本文的文献
1
A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy.一种基于分子特征评分的新型分子分类系统可识别出对免疫疗法和靶向疗法敏感的患者。
Front Immunol. 2024 Nov 26;15:1466069. doi: 10.3389/fimmu.2024.1466069. eCollection 2024.
2
Primary liver cancer spectrum: current knowledge and the next steps.原发性肝癌谱系：当前认知与后续步骤
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):157-160. doi: 10.21037/hbsn-23-607. Epub 2024 Jan 15.
Zotero 插件